1-4 of 4
Todd Meyer, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparison of Platelet-Activating Potential of Bevacizumab+VEGF and Aflibercept+VEGF Complexes

Todd Meyer, PhD., Liza Robles-Carrillo, M.S., Hina Desai, M.S., Meghan Hatfield, M.S., Mildred Amaya, M.S., John Francis, PhD, Ali Amirkhosravi, PhD.
Journal: Blood
Blood (2010) 116 (21): 3200.
https://doi.org/10.1182/blood.V116.21.3200.3200
Published: 2010
Journal Articles

CDP7657, and Other Anti-CD40L Antibody Formats Lacking a Functional Fc Region, Do Not Cause Platelet Activation In Vitro

Ali Amirkhosravi, PhD., Todd Meyer, PhD., Olivier Harari, PhD., Linda Burkly, PhD., Lihe Su, PhD., Yen-Ming Hsu, PhD., Timothy Bourne, PhD., Ian Wakefield, PhD., Christopher Peters, PhD., Anthony Shock, PhD., John Francis, PhD
Journal: Blood
Blood (2010) 116 (21): 5128.
https://doi.org/10.1182/blood.V116.21.5128.5128
Published: 2010
Journal Articles

Platelet Activation by a Humanized Monoclonal CD40 Ligand (CD40L) Antibody.

Todd Meyer, PhD, Ali Amirkhosravi, Ph.D., Theresa Robson, B.A., Mildred Amaya, M.S., Desai Hina, M.S., Lihe Su, Ph.D., Yen-Ming Hsu, Ph.D., Florian Langer, M.D., John L. Francis, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 1516.
https://doi.org/10.1182/blood.V108.11.1516.1516
Published: 2006
Journal Articles

Targeting Angiogenesis in Cancer: Bevacizumab-Induced Platelet Activation as a Possible Cause for Unexpected Arterial Thromboembolic Events in Clinical Trials.

Todd Meyer, PhD, Theresa Robson, B.S., Ali Amirkhosravi, Ph.D., Florian Langer, M.D., Hina Desai, M.S., Mildred Amaya, M.S., Pierre Elias, John L. Francis, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 1091.
https://doi.org/10.1182/blood.V108.11.1091.1091
Published: 2006